White G. Rethinking Your C&GT Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements. April 9, ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes ...

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.